These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34888900)

  • 21. Value of tissue elastography in the prediction of efficacy of neoadjuvant chemotherapy in breast cancer.
    Fang C; Yang TWYZJXW
    J BUON; 2019; 24(2):555-559. PubMed ID: 31128005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram for Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Combining Both Clinicopathological and Imaging Indicators.
    Wang H; Lu Y; Li Y; Li S; Zhang X; Geng C
    Curr Probl Cancer; 2022 Dec; 46(6):100914. PubMed ID: 36351312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound features combined with tumor-infiltrating lymphocytes for prediction of pathological response to neoadjuvant chemotherapy in breast cancer.
    Jia Y; Zhou X; Zhu Y; Song X; Duan Y; Chen K; Nie F
    Med Ultrason; 2023 Jun; 25(2):131-138. PubMed ID: 37369044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
    Luo J; Zhou Z; Yang Z; Chen X; Cheng J; Shao Z; Guo X; Tuan J; Fu X; Yu X
    Medicine (Baltimore); 2016 Feb; 95(8):e2914. PubMed ID: 26937935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Texture analysis based on contrast-enhanced MRI can predict treatment response to neoadjuvant chemotherapy of breast cancer].
    Sun SH; Zhou CW; Zhao LY; Zhang RZ; Ouyang H
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):344-349. PubMed ID: 28535650
    [No Abstract]   [Full Text] [Related]  

  • 26. Usefulness of new shear wave elastography in early predicting the efficacy of neoadjuvant chemotherapy for patients with breast cancer: where and when to measure is optimal?
    Gu JH; He C; Zhao QY; Jiang TA
    Breast Cancer; 2022 May; 29(3):478-486. PubMed ID: 35038129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram.
    Cui H; Zhao D; Han P; Zhang X; Fan W; Zuo X; Wang P; Hu N; Kong H; Peng F; Wang Y; Tian J; Zhang L
    Front Oncol; 2021; 11():718531. PubMed ID: 34888231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators.
    Zhang F; Huang M; Zhou H; Chen K; Jin J; Wu Y; Ying L; Ding X; Su D; Zou D
    Ann Surg Oncol; 2019 Nov; 26(12):3912-3919. PubMed ID: 31359285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram.
    Kim SY; Cho N; Choi Y; Lee SH; Ha SM; Kim ES; Chang JM; Moon WK
    Radiology; 2021 May; 299(2):290-300. PubMed ID: 33754824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of treatment responses to neoadjuvant chemotherapy in breast cancer using contrast-enhanced ultrasound.
    Huang Y; Le J; Miao A; Zhi W; Wang F; Chen Y; Zhou S; Chang C
    Gland Surg; 2021 Apr; 10(4):1280-1290. PubMed ID: 33968680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
    Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
    Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Prediction of Response to Neoadjuvant Chemotherapy Using Quantitative Parameters on Automated Breast Ultrasound Combined with Contrast-Enhanced Ultrasound in Breast Cancer.
    Xie Y; Chen Y; Wang Q; Li B; Shang H; Jing H
    Ultrasound Med Biol; 2023 Jul; 49(7):1638-1646. PubMed ID: 37100671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of conventional ultrasonography combined with contrast-enhanced ultrasonography in the axillary lymph nodes and evaluation of the efficacy of neoadjuvant chemotherapy in breast cancer patients.
    Han X; Jin S; Yang H; Zhang J; Huang Z; Han J; He C; Guo H; Yang Y; Shan M; Zhang G
    Br J Radiol; 2021 Sep; 94(1125):20210520. PubMed ID: 34415197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of strain and shear-wave ultrasounic elastography in predicting the pathological response to neoadjuvant chemotherapy in breast cancers.
    Ma Y; Zhang S; Li J; Li J; Kang Y; Ren W
    Eur Radiol; 2017 Jun; 27(6):2282-2291. PubMed ID: 27752835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China.
    Xiao X; Jiang Q; Wu H; Guan X; Qin W; Luo B
    Eur Radiol; 2017 Jun; 27(6):2443-2450. PubMed ID: 27761708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delta Radiomics Based on Longitudinal Dual-modal Ultrasound Can Early Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Huang JX; Wu L; Wang XY; Lin SY; Xu YF; Wei MJ; Pei XQ
    Acad Radiol; 2024 May; 31(5):1738-1747. PubMed ID: 38057180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer.
    Peng J; Pu H; Jia Y; Chen C; Ke XK; Zhou Q
    Medicine (Baltimore); 2021 May; 100(19):e25908. PubMed ID: 34106653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer.
    Jain P; Doval DC; Batra U; Goyal P; Bothra SJ; Agarwal C; Choudhary DK; Yadav A; Koyalla VPB; Sharma M; Dash P; Talwar V
    Jpn J Clin Oncol; 2019 Apr; 49(4):329-338. PubMed ID: 30753543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of shear-wave elastography versus dynamic optical breast imaging for predicting the pathological response to neoadjuvant chemotherapy in breast cancer.
    Zhang J; Tan X; Zhang X; Kang Y; Li J; Ren W; Ma Y
    Eur J Radiol; 2020 Aug; 129():109098. PubMed ID: 32559591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer.
    Jin X; Jiang YZ; Chen S; Yu KD; Ma D; Sun W; Shao ZM; Di GH
    BMC Cancer; 2016 Aug; 16():606. PubMed ID: 27495967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.